Skip to main content

Lexicon Genetics Extends Deal with Tokyo s Oriental Yeast

NEW YORK, July 10 – Lexicon Genetics said Tuesday it had extended and expanded a marketing collaboration with Oriental Yeast of Tokyo. 

Under the terms of the deal, Oriental Yeast will help Lexicon Genetics of The Woodlands, Texas, to promote its LexVision Database of in vivo mammalian gene function to Japanese pharmaceutical companies. Oriental Yeast will also help to market Lexicon's drug target validation technologies in the Japanese market.

Financial terms of the agreement are not disclosed. 

"The expansion of our contract with [Oriental Yeast] strengthens and confirms Lexicon's commitment to provide in vivo mammalian functional genomics and target validation to the Japanese drug discovery market," Randall Riggs, Lexicon's senior vice president of business development, said in a statement.

During the past year, Lexicon has worked with Oriental Yeast to develop a Japanese-language based website that allows researchers to access Lexicon's OmniBank library, which contains over 150,000 gene knockout clones, or more than 40 percent of all genes in the mammalian genome. 

Oriental Yeast has been involved in the biotech industry since 1968. Four years ago, the company established the Nagahama Institute for Biochemical Sciences, a research center dedicated to researching and developing new compounds. 

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.